Plasmodium falciparum genetic variation of var2csa in the Democratic Republic of the Congo.

TitlePlasmodium falciparum genetic variation of var2csa in the Democratic Republic of the Congo.
Publication TypeJournal Article
Year of Publication2018
AuthorsVerity R, Hathaway NJ, Waltmann A, Doctor SM, Watson OJ, Patel JC, Mwandagalirwa K, Tshefu AK, Bailey JA, Ghani AC, Juliano JJ, Meshnick SR
JournalMalar J
Volume17
Issue1
Pagination46
Date Published2018 Jan 24
ISSN1475-2875
Abstract

BACKGROUND: The Democratic Republic of the Congo (DRC) bears a high burden of malaria, which is exacerbated in pregnant women. The VAR2CSA protein plays a crucial role in pregnancy-associated malaria (PAM), and hence quantifying diversity at the var2csa locus in the DRC is important in understanding the basic epidemiology of PAM, and in developing a robust vaccine against PAM.

METHODS: Samples were taken from the 2013-14 Demographic and Health Survey conducted in the DRC, focusing on children under 5 years of age. A short subregion of the var2csa gene was sequenced in 115 spatial clusters, giving country-wide estimates of sequence polymorphism and spatial population structure.

RESULTS: Results indicate that var2csa is highly polymorphic, and that diversity is being maintained through balancing selection, however, there is no clear signal of phylogenetic or geographic structure to this diversity. Linear modelling demonstrates that the number of var2csa variants in a cluster correlates directly with cluster prevalence, but not with other epidemiological factors such as urbanicity.

CONCLUSIONS: Results suggest that the DRC fits within the global pattern of high var2csa diversity and little genetic differentiation between regions. A broad multivalent VAR2CSA vaccine candidate could benefit from targeting stable regions and common variants to address the substantial genetic diversity.

DOI10.1186/s12936-018-2193-9
Alternate JournalMalar. J.
PubMed ID29361940
PubMed Central IDPMC5782373
Grant ListR01 AI099473 / AI / NIAID NIH HHS / United States
R01 AI121558 / AI / NIAID NIH HHS / United States
R21 AI121465 / AI / NIAID NIH HHS / United States
5 R01 AI099473 / / National Institutes of Health / United States
R56 AI106129 01A1 / / National Institutes of Health / United States
109312/Z/15/Z / / Wellcome Trust / United Kingdom
R01 AI107949 / AI / NIAID NIH HHS / United States
5R01AI107949 / / National Institutes of Health / United States
MR/N01507X/1 / / UK Medical Research Council / United States
/ / Wellcome Trust / United Kingdom
R21AI121465 / / National Institutes of Health / United States
R56 AI106129 / AI / NIAID NIH HHS / United States
R01AI121558 / / National Institutes of Health / United States

Person Type: